Investigating how to prevent arrhythmias and sudden cardiac death by targeting protein trafficking.
Targeting Protein Trafficking in Arrhythmogenic Cardiomyopathy
This study is looking at how a special protein in heart cells helps keep your heart beating normally, which could lead to new ways to prevent dangerous heart problems like arrhythmias and sudden cardiac death.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10914054 on NIH RePORTER |
What this research studies
This research focuses on understanding how proteins are transported within heart cells to prevent arrhythmias and sudden cardiac death. The principal investigator, Joseph Palatinus, MD, PhD, is working under the mentorship of renowned experts in the field. The approach involves studying a specific protein, Connexin 43, and its role in maintaining proper heart function, particularly in models of arrhythmogenic cardiomyopathy. By using both laboratory experiments and animal models, the research aims to uncover new therapeutic strategies for heart disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with arrhythmogenic cardiomyopathy or those at risk for arrhythmias.
Not a fit: Patients with non-cardiac related conditions or those without arrhythmogenic cardiomyopathy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly reduce the risk of arrhythmias and sudden cardiac death in patients with heart conditions.
How similar studies have performed: Previous research has shown promise in targeting protein trafficking for cardiac conditions, suggesting that this approach may lead to significant advancements in treatment.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Palatinus, Joseph a. — University of Utah
- Study coordinator: Palatinus, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.